The e#ects on blood coagulation of dipicolinic acid (DPA, ,,0-pyridinedicarboxylic acid), an antibacterial substance known to be produced by Bacillus subtilis natto and contained in natto, a traditional Japanese fermented soybean food, were studied. It was found that addition of DPA with a final concentration of /῍+* ῌ-M results in substantial inhibition of platelet aggregation. DPA inhibition was found to be far stronger than that resulting from addition of aspirin. Furthermore, the clotting reaction of thrombinfibrinogen was also found to be inhibited by DPA. It was confirmed by examination of thromboelastogram patterns that the coagulation of whole rat blood was completely inhibited by addition of /῍+* ῌ-M DPA. From the point of view of the blood coagulation system, these results show that DPA contained in natto may be e#ective in the prevention of thrombosis.
Introduction
It has been reported that nattokinase (Sumi et al., +321) , a strong plasmin-like enzyme is produced by Bacillus subtilis natto, and that fibrinolysis occurs in the blood after intake of natto, a traditional fermented food produced using Bacillus subtilis natto (Sumi et al., +33* ; ,**.). Natto also contains large amounts of FAS (Sumi et al., ,***a), a fibrinolysis-accelerating substance, and vitamin K (menaquinone-1), which, in contrast, is e#ective in the synthesis of blood coagulation factors (Sumi et al., +333) . Another physiologically active substance which has been known for some time to be contained in natto is dipicolinic acid (DPA), which shows strong activity against S. aureus, Vibrio, E. coli and yeasts (Udoh., . The amount of DPA contained in natto products sold on the market was recently quantified, with the observation that a large amount, approximately ,*.//ῌ+-.01 mg, is contained in every +** g of natto (Sumi and Ohsugi., +33* ; Sumi et al., ,***b). Because a fairly large amount of DPA is naturally consumed via intake of natto, its physiological e#ects cannot be ignored. However, the e#ects of DPA on blood coagulation and fibrinolysis systems have not yet been investigated. Using aspirin as a positive control, we conducted a test which confirmed that DPA exhibits strong anti-platelet-aggregation and thrombininhibition activities. What follows is a report on these findings.
Materials and methods
Materials Dipicolinic acid (DPA, ,,0-pyridinedicarboxylic acid), purchased from Nacalai Tesque Inc., and aspirin, purchased from Sigma Co., Ltd., were each dissolved in water and neutralized with NaOH before use. Bovine fibrinogen and adenosine diphosphate (ADP) were purchased from Sigma Co., Ltd., and bovine thrombin was purchased from Mochida Pharmaceutical Co., Ltd. Synthetic peptide substrate H-D-Phe-Pip-Arg-pNA (S-,,-2) was purchased from Chromogenix.
Platelet aggregation Blood was drawn from a Wistar male rat (weight : about -.* g) and a New Zealand White male rabbit (weight : about -kg), both etherized, using citrate at + : +* by volume. Fractionation of platelet-rich plasma (PRP) was carried out by centrifugal separation performed at +**῍g for ten minutes, and fractionation of platelet-poor plasma (PPP) was carried out by centrifugal separation of the remainder at ,***῍g for ten minutes. Fifty microliters of PRP, +** ml of Tyrode's bu#er solution and /* ml of DPA solution were added to the cuvette of an aggregometer (PAT-.A : Mebanix). After pre-incubation at -1῎ for five minutes, ,, ml of ADP solution (final concentration : -* mM) was added as an aggregation trigger substance, and changes in turbidity over five minutes were measured by the aggregometer.
Clotting time Using *.+1 M borate-saline bu#er (BSB), *./ ml of fibrinogen solution, prepared at *.2ῌ, and *./ ml DPA solution were placed in a test tube (f +-῍+** mm), and after pre-incubation at -1῎ for ten minutes, *.+ ml of ,* U/ml thrombin solution was added and the elapsed E-mail : ohsugi@chem.kusa.ac.jp
Food Sci. Technol. Res., ++ (-), -*2ῌ-+*, ,**/ time until complete formation of fibrin was measured at -1῎. Amidolytic activity Ten microliters of +* U/ml thrombin solution, -* ml of PBS and /* ml of DPA solution were mixed on a 30-well micro test plate, and after pre-incubation at -1῎ for ten minutes, +* ml of /῍+* ῌ-M synthetic peptide substrate solution (S-,,-2) was added and changes in absorbance at .*/ nm were measured using a BioKinetics Reader (EL -+,e : Bio-Tec Instruments Inc.).
Thromboelastography Whole rat blood (*.-ml) and DPA solution (*.*+ ml) were added to a cell, and coagulation and fibrinolysis patterns were monitored for two hours at -1῎ using a Clot-Tracer (TE-1** : Erma Inc.) (Otsuka et al., +32*).
Results and Discussion
Platelet aggregation patterns were observed for rat blood with ADP as the aggregation trigger substance, and it was found that the addition of DPA caused a reduction in aggregation patterns. Figure + shows the aggregation inhibition rate of DPA at various concentration levels ; the rate shows a dose-dependent rise at DPA concentrations of +.*ῌ/.*῍+* ῌ-M. The calculated IC/* was a low concentration of +.02῍+* ῌ-M, which shows that aggregation inhibition was stronger than that observed for aspirin (IC/* : ..*῍+* ῌ, M). Although not shown in the figure, the results were almost identical in the case of rabbit blood platelets (IC/* : ,.,῍+* ῌ-M). Figure , shows the results of the tests studying the e#ects of DPA on the coagulation reaction in which fibrinogen, a water-soluble protein, is converted by thrombin into insoluble fibrin. Whereas the clotting time was three minutes when one unit of thrombin was used as a control, this was extended by three times by addition of DPA at +.-1῍+* ῌ, M. Furthermore, the clotting time was extended by 2., times by addition of DPA at ,.1/῍+* ῌ, M, and +0.. times by addition of DPA at /./῍+* ῌ, M, which shows that DPA is e#ective for inhibition of fibrin formation. As shown in Figure , , the inhibition of the coagulation reaction by DPA was stronger than that of aspirin. (The clotting time measured for aspirin solution at a concentration of +.*῍+* ῌ, M was five minutes.) However, a study of the e#ects using H-D-Phe-Pip-ArgpNA (S-,,-2), a specific substrate of thrombin, revealed that, as shown in Fig. - , no inhibition at or exceeding /*ῌ was observed for one unit of thrombin with addition of DPA at +.,/῍+* ῌ-Mῌ,.*῍+* ῌ, M. In order to examine the e#ects of DPA on the fibrinolysis system, DPA was added to urokinase (UK), but no inhibition was observed. A study of the e#ects of DPA on whole rat blood was conducted based on thromboelastogram patterns (Fig. .) . With no DPA added, the reaction time (r value) was 3.+ῌ +*.+ min, the clot formation time (k value) was ,.0ῌ.., min, and the maximum amplitude (Ma value) was /1.2ῌ0*.-mm (n῎-) ; a reduction in each value was observed as a result of the addition of DPA at ,.*῍+* ῌ-M, with the r value at ++.0ῌ+..-min, the k value at -./ῌ1.. min, and the Ma value at .0.*ῌ/..2 mm. It was found that further raising the concentration of DPA to /.*῍+* ῌ-M, resulted in an r value of +/./ min or more, a k value of * min and an Ma value of *ῌ+,./ mm, which indicates strong blood coagulation inhibition.
It was reported as a result of preliminary tests that, along with nattokinase (Sumi et al., +321 ; +33* ; ,**.), which is a plasmin-like enzyme and FAS (fibrinolysis accelerating substance) (Sumi et al., ,***a), the water-soluble fraction of natto is also active in inhibiting platelet aggregation (Sumi et al., ,***c). In the current series of tests (Figs. +ῌ.), it was established for the first time that platelet aggregation inhibition activity is derived from DPA itself. It was found that DPA is very active in anti-platelet aggregation ; its inhibition reaction is stronger than that of aspirin under the same conditions. It is estimated from a calculation based on overall consumption of natto that the average intake of DPA by Japanese people is around *..ῌ..* mg/day (Nagayama., +33*) ; from a physiological point of view, these amounts cannot be ignored. Although it was previously thought that a substantial amount of DPA exists among Bacillus spores, recent analyses of the fermented foodstu# natto clarified that the DPA content is in fact quite substantial, and that some DPA is also present outside the spores in the watersoluble fractions (Sumi and Ohsugi, +33* ; Sumi et al., ,*** b).
Because the platelet aggregation reaction acts as a trigger for blood coagulation, it is believed that inhibiting sequent platelet aggregation is of considerable value. In view of the e#ects of DPA on the blood coagulation system, it is hoped that active ingestion of DPA may prove helpful in the prevention and treatment of thrombosis.
